116 related articles for article (PubMed ID: 34055650)
21.
Dyrberg E; Hendel HW; Huynh THV; Klausen TW; Løgager VB; Madsen C; Pedersen EM; Pedersen M; Thomsen HS
Eur Radiol; 2019 Mar; 29(3):1221-1230. PubMed ID: 30132104
[TBL] [Abstract][Full Text] [Related]
22. Penile Metastasis from Prostate Cancer Presenting as Malignant Priapism Detected Using Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
Kamaleshwaran KK; Balasundararaj BKP; Jose R; Shinto AS
Indian J Nucl Med; 2018; 33(1):57-58. PubMed ID: 29430118
[TBL] [Abstract][Full Text] [Related]
23. 68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy.
Kesler M; Druckmann I; Levine C; Kuten J; Yossepowitch O; Even-Sapir E
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33578990
[TBL] [Abstract][Full Text] [Related]
24. Added value of
Zacho HD; Ravn S; Afshar-Oromieh A; Fledelius J; Ejlersen JA; Petersen LJ
EJNMMI Res; 2020 Apr; 10(1):31. PubMed ID: 32270300
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Role of
Awenat S; Piccardo A; Carvoeiras P; Signore G; Giovanella L; Prior JO; Treglia G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33808825
[TBL] [Abstract][Full Text] [Related]
26. Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT.
Ross MI; Bird N; Mendichovszky IA; Rimmer YL
EJNMMI Res; 2020 Sep; 10(1):108. PubMed ID: 32960378
[TBL] [Abstract][Full Text] [Related]
27. Intraindividual Comparison of
Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
[TBL] [Abstract][Full Text] [Related]
28. Rare Sites of Metastases in Prostate Cancer Detected on Ga-68 PSMA PET/CT Scan-A Case Series.
Dureja S; Thakral P; Pant V; Sen I
Indian J Nucl Med; 2017; 32(1):13-15. PubMed ID: 28242977
[TBL] [Abstract][Full Text] [Related]
29. Optimized Application of
Qin C; Gai Y; Liu Q; Ruan W; Liu F; Hu F; Zhang X; Lan X
Front Med (Lausanne); 2021; 8():657619. PubMed ID: 34055836
[No Abstract] [Full Text] [Related]
30. Orbital and brain metastases on
Parihar AS; Chandekar KR; Singh H; Sood A; Mittal BR
Asia Ocean J Nucl Med Biol; 2021; 9(1):67-70. PubMed ID: 33392353
[TBL] [Abstract][Full Text] [Related]
31. The Value of
Madsen C; Østergren P; Haarmark C
Diagnostics (Basel); 2020 May; 10(6):. PubMed ID: 32481743
[TBL] [Abstract][Full Text] [Related]
32. The value of
Hong JJ; Liu BL; Wang ZQ; Tang K; Ji XW; Yin WW; Lin J; Zheng XW
EJNMMI Res; 2020 Nov; 10(1):138. PubMed ID: 33169183
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
[No Abstract] [Full Text] [Related]
34. [
Hirmas N; Al-Ibraheem A; Herrmann K; Alsharif A; Muhsin H; Khader J; Al-Daghmin A; Salah S
Mol Imaging Biol; 2019 Jun; 21(3):574-581. PubMed ID: 30215174
[TBL] [Abstract][Full Text] [Related]
35. Dual-Time Point [
Hoffmann MA; Buchholz HG; Wieler HJ; Rosar F; Miederer M; Fischer N; Schreckenberger M
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32998432
[TBL] [Abstract][Full Text] [Related]
36. Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop.
Gupta M; Choudhury PS; Rawal S; Goel HC; Talwar V; Singh A; Sahoo SK
World J Nucl Med; 2018; 17(4):261-269. PubMed ID: 30505224
[TBL] [Abstract][Full Text] [Related]
37. Intraindividual Comparison of
Kesch C; Vinsensia M; Radtke JP; Schlemmer HP; Heller M; Ellert E; Holland-Letz T; Duensing S; Grabe N; Afshar-Oromieh A; Wieczorek K; Schäfer M; Neels OC; Cardinale J; Kratochwil C; Hohenfellner M; Kopka K; Haberkorn U; Hadaschik BA; Giesel FL
J Nucl Med; 2017 Nov; 58(11):1805-1810. PubMed ID: 28473595
[No Abstract] [Full Text] [Related]
38. Head to head comparison performance of
García-Pérez FO; Davanzo J; López-Buenrostro S; Santos-Cuevas C; Ferro-Flores G; Jímenez-Ríos MA; Scavuzzo A; Santana-Ríos Z; Medina-Ornelas S
Am J Nucl Med Mol Imaging; 2018; 8(5):332-340. PubMed ID: 30510850
[TBL] [Abstract][Full Text] [Related]
39. New aspects of molecular imaging in prostate cancer.
Ceci F; Castellucci P; Cerci JJ; Fanti S
Methods; 2017 Nov; 130():36-41. PubMed ID: 28711565
[TBL] [Abstract][Full Text] [Related]
40. See the unseen: Mesorectal lymph node metastases in prostate cancer.
Hijazi S; Meller B; Leitsmann C; Strauss A; Ritter C; Lotz J; Meller J; Trojan L; Sahlmann CO
Prostate; 2016 Jun; 76(8):776-80. PubMed ID: 26880517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
